-
Bull, Housser & Tupper LLP
-
Business In Vancouver
-
Aurinia Pharmaceuticals
-
Aurora Biomed Inc.
-
A
-
BioTalent Canada
-
B
-
Nucleo Life Sciences
-
C
-
D
-
E
-
AbbVie Corporation
-
F
-
G
-
H
-
I
-
J
-
B.C. Technology Industry Association
-
ACCT Canada
-
K
-
BC Cancer Agency
-
L
-
BC Preclinical Research Consortium
-
M
-
Innovate BC
-
N
-
Biocan Diagnostics Inc.
-
O
-
P
-
Biolux Research Ltd.
-
Q
-
ACETECH
-
R
-
S
-
T
-
AdvantageBC
-
U
-
Biopep Solutions Inc.
-
BioPharma Solutions
-
Aequus Pharmaceuticals Inc
-
V
-
W
-
X
-
BIOTECanada
-
Ag-West Bio Inc.
-
Z
-
Blake, Cassels & Graydon LLP
-
Blender Media
-
Alectos Therapeutics Inc.
-
Boehringer Ingelheim (Canada) Ltd.
-
Amgen British Columbia Inc.
-
AON
-
Aquila Veterinary Diagnostics Ltd.
-
Aquinox Pharmaceuticals Inc.
-
Molecular You
-
Boreal Genomics
-
ARC Medical Devices Inc.
-
Aspect Biosystems Ltd.
-
Aspera, an IBM company
-
Bovicor Pharmatech Inc.
-
AstraZeneca Canada Inc.
-
Augurex Life Sciences Corp.
-
British Columbia Centre for Excellence in HIV/AIDS
-
British Columbia Clinical Research Infrastructure Network
Boreal Genomics
Address:
302 – 2386 East Mall
Vancouver, BC
V6T 1Z3
Canada
Phone: 604.822-8268
Fax: 604-822-2938
Member Sector: Contract Research & Scientific Services
Boreal Genomics is a rapidly expanding cancer diagnostic testing company focused on circulating tumor DNA analysis from a simple blood draw. Boreal develops and commercializes assays for pharmaceutical research, clinical research and routine clinical testing for cancer diagnostic, surveillance, and screening applications. The assay platform has been optimized for the detection of circulating somatic mutations in plasma where cancer sequences are typically overwhelmed by normal background. Using a novel, patented and highly selective target enrichment and sequencing method, this technology enriches cancer DNA over normal DNA a by 1,000,000-fold to allow highly multiplexed, efficient, quantitative, and sensitive mutation detection. Boreal holds an exclusive license to a broad patent portfolio from the University of British Columbia on the company’s platform technology. The company operates with corporate headquarters in Silicon Valley, CA and an R&D site in Vancouver, Canada.